ZUG, Switzerland, Dec. 8, 2021 /PRNewswire/ -- SHL Medical, a world-leading solutions provider in the design, development, and manufacturing of self-injection devices, announced the publication of its ...

TAOYUAN, TAIWAN — For Taiwanese injection molder SHL Group, a niche focus manufacturing devices for a new class of pricey biologically-based drugs has become big business, to the tune of $140 million ...

ZUG, Switzerland, May 3, 2023 – MoonLake Immunotherapeutics (MLTX) (“MoonLake”), a clinical-stage biotechnology company focused on creating next-level therapies for inflammatory diseases, today ...

Drug injector device maker SHL Group is investing $40 million this year at its injection molding facilities in Taiwan in response to new product launches by customers in the pharmaceutical sector. SHL ...

ZUG, Switzerland, April 1, 2025 /PRNewswire/ -- SHL Medical, a global leader in the design, development, and manufacturing of advanced self-injection solutions, has officially inaugurated its new ...

Swiss-based SHL Medical has opened a new autoinjector manufacturing facility in North Charleston, South Carolina, US, with a $220m investment. This 360,000ft² site will help the company meet the ...

Drug delivery specialist SHL Medical opened the doors to its new $220 million autoinjector production facility in South Carolina, further boosting the Swiss company’s global footprint. The facility, ...

ZUG, Switerland, May 3, 2023 /PRNewswire/ -- SHL Medical, a world-leading provider of advanced drug delivery solutions, announced that it has signed a collaboration agreement with MoonLake ...